BiotechTubeBiotechTube
Home/Oxford Biomedica/Peter Soelkner
PS

Peter Soelkner

Vice Chair of the Board of Directors

Oxford Biomedica

Therapeutic Areas

OncologyRare DiseasesNeurologyOphthalmologyHematology

Oxford Biomedica Pipeline

DrugIndicationPhase
Kymriah (Novartis) - LV Vector SupplyB-cell Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-Cell Lymphoma (DLBCL)Approved

Leadership Team at Oxford Biomedica

DR
Dr. Roch Doliveux
Chair of the Board of Directors
DF
Dr. Frank Mathias
Chief Executive Officer
PD
Professor Dame Kay Davies
Senior Independent Director
CB
Colin Bond
Independent Non-Executive Director
DL
Dr. Lucinda Crabtree
Chief Financial Officer
LE
Laurence Espinasse
Non-Executive Director
NP
Namrata P Patel
Independent Non-Executive Director
DH
Dr. Heather Preston
Independent Non-Executive Director
LD
Lisa Doman
Chief People Officer
DM
Dr. Melanie Kearney
Global Head of Quality
View full Oxford Biomedica profile